NP | Jotup

NPHub Joins Forces with the Florida Association of Nurse Practitioners to Accelerate Nurse Practitioner Education in Florida

Retrieved on:

Wednesday, November 8, 2023

Education, Nurse practitioner, Florida Association of Band Directors, Health, University, Student, Partnership, NP, Algorithm, Nursing

ATLANTA, Nov. 8, 2023 /PRNewswire-PRWeb/ -- NPHub, a pioneering healthcare technology firm, is thrilled to announce a strategic alliance with the Florida Association of Nurse Practitioners (FLANP). This partnership is set to revolutionize the clinical rotation placement process for nurse practitioner students in Florida through NPHub's industry-leading app. By connecting students and preceptors seamlessly, this initiative promises a more streamlined and efficient graduation pathway for NP students."

Key Points:

NPHub announces a strategic partnership with the Florida Association of Nurse Practitioners to streamline clinical rotations for Nurse Practitioner students in Florida, enhancing education and patient care through NPHub's innovative app.
ATLANTA, Nov. 8, 2023 /PRNewswire-PRWeb/ -- NPHub, a pioneering healthcare technology firm, is thrilled to announce a strategic alliance with the Florida Association of Nurse Practitioners (FLANP).
This partnership is set to revolutionize the clinical rotation placement process for nurse practitioner students in Florida through NPHub's industry-leading app.
"Revolutionizing NP education in Florida, our alliance with FLANP paves the way for a seamless clinical rotation experience."

New Research Shows High Accuracy of Precivity™ Blood Biomarkers in the Evaluation of Brain Amyloid in Pre-Clinical Alzheimer's Disease

Retrieved on:

Tuesday, November 7, 2023

C2N analyzed the biomarkers using its high-resolution mass spectrometry (MS) analytical platform as part of this study.

Key Points:

C2N analyzed the biomarkers using its high-resolution mass spectrometry (MS) analytical platform as part of this study.
All participants underwent amyloid PET scans, and 340 (32%) participants had positive PET scan findings (defined as Centiloid scale > 20).
Among the individual biomarkers evaluated, plasma p-tau217/np-tau217 had highest accuracy followed next by Aβ42/Aβ40 and last by p-tau181/np-tau181 for identifying amyloid PET status.
“The blood biomarkers with the highest performance in the study are the biomarkers highlighted in the Precivity blood tests, demonstrating the application of these biomarkers for important research purposes.

PowerTap Provides Bi-Weekly Status Report

Retrieved on:

Saturday, October 28, 2023

Hydrogen, Principal, SHIM, OTC, British Columbia Securities Commission, News, Acquisition, Bank statement, Chartered accountant, FinCEN Files, Trinity College, University of Toronto, Annual Filing Season Program, National Policy, University, NP, NEO, Accounting, Security (finance)

During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.

Key Points:

During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.
However, the Company's Chief Executive Office and Chief Financial Officer will not be able to trade in the Company's common shares.
Mr. McIntosh has specific expertise in financial operations management, financial administration and control, M&A, and both project and acquisition financing.
The Company confirms that it intends to satisfy the provisions of NP 12- 203 and will continue to issue bi-weekly default status reports for so long as it remains in default of the Annual Filings requirement.

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON'S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Retrieved on:

Thursday, October 26, 2023

PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects. The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here.

Key Points:

PENSACOLA, Fla., Oct. 26, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.
The case study titled "Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Study," was published by Walsh Medical Media and can be accessed in its entirety here.
After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days.
"A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary.

NP Digital Named an Adweek Fastest Growing Agency for the Third Consecutive Year

Retrieved on:

Wednesday, October 25, 2023

Digital, Acquisition, Adobe, Content, Universal Technical Institute, SEO, Growth, SoFi, NP, ConnectWise Control, AI, PPC, SAN, Mobile phone

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- NP Digital , a global leader in end-to-end performance marketing, has shown impressive international and US growth, earning its third year on Adweek’s Fastest Growing Agencies list.

Key Points:

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- NP Digital , a global leader in end-to-end performance marketing, has shown impressive international and US growth, earning its third year on Adweek’s Fastest Growing Agencies list.
Over the last year, the agency deepened its expertise in marketplaces, creative testing, conversion rate optimization, and data and analytics.
The additional solutions bolster NP Digital’s omnichannel offering in the U.S. and support a growing global team of local experts.
“We’ve been steadfast in our growth in all areas of the business and are proud to celebrate this hard-earned recognition,” said Mike Gullaksen, CEO of NP Digital.

PowerTap Provides Bi-Weekly Status Report

Retrieved on:

Thursday, October 12, 2023

Hydrogen, OTC, SEC filing, SHIM, Bank statement, Annual Filing Season Program, NP, British Columbia Securities Commission, National Policy, News, NEO, Audit

During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.

Key Points:

During the MCTO, the general investing public will continue to be able to trade in the Company's listed common shares.
However, the Company's Chief Executive Office and Chief Financial Officer will not be able to trade in the Company's common shares.
The audit committee, the Board and management authorizes SHIM to respond fully to any enquiries by a successor auditor.
The Company confirms that it intends to satisfy the provisions of NP 12- 203 and will continue to issue bi-weekly default status reports for so long as it remains in default of the Annual Filings requirement.

REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, ANNOUNCE NEW CARE ADVANCEMENTS USING WHARTON'S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS

Retrieved on:

Tuesday, October 3, 2023

PENSACOLA, Fla., Oct. 3, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.

Key Points:

PENSACOLA, Fla., Oct. 3, 2023 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective case series demonstrating new care advancements using its Wharton's Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects.
Standard treatment includes simply resting the jaw muscles and avoiding use, massage, physical therapy, medication management, and, when all else fails, surgery.
After one application of Regenative's Wharton's Jelly allograft, the patient's pain improved by an average of 75% after 90 days.
"A few years ago, we started using PRF (platelet-rich fibrin) therapy in the jaw joint, and we thought that was revolutionary.

Zivian Health Partners with Matchday to Reduce Physician Burnout and Bring Back the Joy of Medicine

Retrieved on:

Thursday, September 21, 2023

Zivian Health will present at Matchday’s Moonshot launch event today in Austin to announce the partnership.

Key Points:

Zivian Health will present at Matchday’s Moonshot launch event today in Austin to announce the partnership.
Matchday will expand specialty care collaborations with physicians who can now continue meaningful clinical work and balance with patient-facing care.
Matchday will provide the first six months free for any physician signing up for Zivian.
Zivian Health now supports primary care practices and specialty care throughout the country, such as women's health and behavioral health, with new expansion into other specialty care areas, including gastroenterology and fertility medicine.

SAC Health Wins National Award for Innovative Care in Vaccine Delivery

Retrieved on:

Wednesday, September 20, 2023

SAN BERNARDINO, Calif., Sept. 20, 2023 /PRNewswire-PRWeb/ -- SAC Health was awarded the Innovation Award in Community Health: Addressing Infectious Disease in Underserved Communities. SAC Health was among 19 community health centers and free and charitable clinics in the U.S., which received the award from The Pfizer Foundation and Direct Relief. This award recognizes programs which are improving access to education and treatment for vaccine-preventable infectious diseases among medically underserved communities across the United States.

Key Points:

SAN BERNARDINO, Calif., Sept. 20, 2023 /PRNewswire-PRWeb/ -- SAC Health was awarded the Innovation Award in Community Health: Addressing Infectious Disease in Underserved Communities.
SAC Health was among 19 community health centers and free and charitable clinics in the U.S., which received the award from The Pfizer Foundation and Direct Relief.
SAC Health received $250,000 to support a two-year program aimed at providing quality care to at-risk populations and will implement the SAVE-IE program.
Information about the Innovations in Care Award winners, including project information and photos can be found at: www.directrelief.org/partnership/pfizer/#innovation .

Blackmagic Design Announces New Blackmagic Cinema Camera 6K

Retrieved on:

Thursday, September 14, 2023

(Photo: Business Wire)

Key Points:

(Photo: Business Wire)
The Blackmagic Cinema Camera 6K will be demonstrated on the Blackmagic Design IBC 2023 booth #7.C49.
"With the new Blackmagic Cinema Camera 6K, we wanted to create the most portable camera possible for high end, large format cinematography," said Grant Petty, Blackmagic Design CEO.
Blackmagic Cinema Camera 6K is available now for US$2,595, excluding local duties and taxes, from Blackmagic Design resellers worldwide.
Product photos of the Blackmagic Cinema Camera 6K, as well as all other Blackmagic Design products, are available at www.blackmagicdesign.com/media/images .